FY25 to-b

Active Awarded Last action

Contract number
75N91025F00007
Awardee
Awarding agency
Obligated
$2,034,923

Award facts

Contract value 100% obligated
$2,034,923.00 Current and potential, with all options
Completion date 54% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Frederick, MD 21702, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 -$17,849
Original award $2,052,772

About this award

The National Cancer Institute issued a $2,034,923 delivery order to Leidos Biomedical Research Inc. on September 17, 2025, with an ultimate completion date of September 30, 2027, under a cost-plus-fixed-fee pricing structure.

Leidos Biomedical Research Inc. is a Federally Funded Research and Development Center (FFRDC) contractor subsidiary of Leidos Holdings, Inc., providing biomedical research and facilities support services to the National Cancer Institute and National Institutes of Health. Place of performance is Frederick, MD 21702. No set-aside was used for this delivery order.

Quick answers

Who was awarded contract 75N91025F00007?

75N91025F00007 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 17, 2025.

How much is contract 75N91025F00007 worth?

The government has obligated $2,034,923 on 75N91025F00007.

Is contract 75N91025F00007 an order under another contract?

Yes. 75N91025F00007 is a delivery order under 75N91019D00024, an indefinite delivery contract.

Was contract 75N91025F00007 competed?

The extent of competition for 75N91025F00007 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award